NIH-funded research Fellowship grant

Understanding how PRMT5 modifies histones to regulate gene expression in leukemia

Official title: Molecular Basis of Histone Methylation by PRMT5

Funded at Johns Hopkins University · NIH-11053617 · Data updated 2026-11-12

This study is looking at how a protein called PRMT5 changes other proteins that help organize DNA, with the goal of finding new ways to treat acute myeloid leukemia and other cancers.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionJohns Hopkins University
NIH-funded
Lab location1 site (Baltimore, United States)
Project startApril 1, 2023
Project endApril 29, 2025
Funding year2025
Award (this year)$20,675
NIH project number5F31CA271743-03
Project IDNIH-11053617 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients diagnosed with acute myeloid leukemia or related hematological malignancies.

Less likely to help

Patients with solid tumors or those not diagnosed with acute myeloid leukemia may not benefit from this research.

What this research studies

This research investigates the role of Protein Arginine Methyltransferase 5 (PRMT5) in modifying histones, which are proteins that help package DNA in cells. By studying how PRMT5 interacts with histones and the effects of these modifications on gene expression, the research aims to uncover mechanisms that could lead to new treatments for acute myeloid leukemia and other cancers. The approach involves biochemical assays and molecular biology techniques to analyze the methylation process and its implications for cancer progression.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating acute myeloid leukemia by targeting the mechanisms of gene regulation.

How similar studies have gone: Previous research has shown that targeting histone modifications can be effective in treating various cancers, suggesting a promising avenue for this approach.

Where this research is happening

  • Johns Hopkins University
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Rahman, Sanim — Johns Hopkins University
  • Study coordinator: Rahman, Sanim

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.